Dr. Linda Marbán

CEO at Capricor Therapeutics
On the record
Represented by:
Recent Quotes
Sign up to view all
  • As hospitalizations continue to steadily increase heading into the New Year, the DSMB’s recommendation is vital as we continue this study to potentially help patients who are at a high risk for significant morbidity or even death. Given that CAP-1002 polarizes macrophages to an anti-inflammatory, healing immunomodulatory phenotype, it may subsequently attenuate the effects of the cytokine storm associated with severe COVID-19.

    18 January 2021
Employment
Sign up to view all
  • Capricor Therapeutics
    CEO